Study on the cellular and humoral immunity effect of recombinant Chinese hamster ovary cell hepatitis B vaccine in adults.
- Author:
Wei ZHANG
1
;
Li-li HAN
;
Chang-ying LIN
;
Li-qiu LI
;
Pei GAO
;
Hui LIN
;
Xiao-hong GONG
;
Fang HUANG
;
Ya-qing TANG
;
Jian-xin MA
;
Hai-yan ZHANG
;
Chen WANG
;
Peng YANG
;
Hui LI
;
Jiang WU
;
Mei-ping SUN
;
Xiong HE
;
Xing-huo PANG
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Adult; Animals; Antibody Formation; CHO Cells; Cricetinae; Cricetulus; Double-Blind Method; Female; Hepatitis B; prevention & control; Hepatitis B Antibodies; blood; immunology; Hepatitis B Vaccines; administration & dosage; immunology; Humans; Immunity, Cellular; immunology; Male; Middle Aged; Young Adult
- From: Chinese Journal of Preventive Medicine 2010;44(10):918-922
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo evaluate the cellular and humoral immunity effect of 10 µg and 20 µg recombinant Chinese hamster ovary (CHO) cell hepatitis B vaccine in adults by randomized double-blind controlled trials.
METHODA total of 642 adults aged 18 - 45 years old, non-vaccinated against hepatitis B, and hepatitis B five blood indicators negative were selected as the study subjects. The study subjects were randomly divided into two groups and each group had 321 subjects. The subjects were given 10 µg and 20 µg recombinant CHO hepatitis B vaccination respectively by 0, 1st, 6th month schedule. Blood sample was collected from each study subject one month after the second dose vaccination. The anti-HBs level was detected by Abbott chemiluminescence detection method (I2000) to evaluate humoral immunity status. Of all the study objects, 153 cases were randomly selected by the Excel random function. Their blood samples were collected and Lymphocyte were separated to detect the IL-4 and IFN-γ levels in vitro by enzyme-linked immunospot (ELISPOT) method to evaluate the cellular immunity status.
RESULTSThe anti-HBs seroconversion rates in 10 µg and 20 µg dose group were 88.8% (285/321) and 95.3% (306/321) respectively, and 95%CI were 85.4% - 92.2% and 93.0% - 97.6% respectively. The spot forming cell (SFC) of IL-4 of the 20 µg-dose group (x(-) = 20.31) were significantly higher than the 10 µg-dose group (x(-) = 8.19, t = 3.27, P < 0.01). With the increasing of anti-HBs titer, the SFC of IL-4 also went up significantly. There was a positive correlation between SFC of IL-4 and anti-HBs (Spearman correlation coefficient = 0.538, P < 0.0001). No significant difference was found for IFN-γ SFC in two groups (10 µg group: x(-) = 1.49; 20 µg group: x(-) = 0.86; t = 1.83, P > 0.05).
CONCLUSIONThe humoral and cellular immune effects of 20 µg recombinant CHO hepatitis B vaccine are better than that of the 10 µg recombinant CHO hepatitis B vaccine.20 µg recombinant CHO hepatitis B vaccine should be chosen as the adult's hepatitis B prevention vaccine.
